<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45127">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01777126</url>
  </required_header>
  <id_info>
    <org_study_id>ERONP</org_study_id>
    <nct_id>NCT01777126</nct_id>
  </id_info>
  <brief_title>Implementation of an Enhanced Recovery Oral Nutrition Protocol After Unproblematic Radical Cystectomy Reduces Interval to Discharge.</brief_title>
  <acronym>ERONP</acronym>
  <official_title>Implementation of an Enhanced Recovery Oral Nutrition Protocol After Unproblematic Radical Cystectomy Reduces Interval to Discharge.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After radical cystectomy, postoperative ileus (POI) is a common complication resulting in a
      delayed oral nutritional intake with prolonged recovery and hospital stay. However, it is
      questionable if nutritional support by routine use of parenteral nutrition (PN) is
      justifiable or cost-effective.

      This study includes patients undergoing elective unproblematic radical cystectomy in a
      single institution. In the control group there are no parenteral nutrition (PN)
      restrictions. In the experimental group, an Enhanced Recovery Oral Nutrition Protocol
      (ERONP) will be introduced and PN can be initiated if oral intake is still insufficient
      after five days. Outcome measure are postoperative length of stay.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>the postoperative length of stay</measure>
    <time_frame>one month after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Radical Cystecomy</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects enrolled in this arm will undergo usual medical and pharmaceutical care. In this group, parenteral nutrition (Oliclinomel N7) is part of the routine postoperative care program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Recovery Oral Nutrition Protocol (ERONP) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects enrolled in this arm will undergo the ERONP protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Recovery Oral Nutrition Protocol (ERONP) group</intervention_name>
    <description>For the experimental group, an enhanced oral nutrition protocol (ERONP) with restrictive instructions for parenteral nutrition is implemented. Oral intake is increased progressively with oral fluids and easily digestible food, independent of clinical bowel movements. The oral energy sips used are Fortimel Juicy® (Nutricia) 200 ml containing 300 kcal. This provides supplementary energy and essential nutrients. Supplementary fluid, approximately up to two liter, is given intravenously. If the patient is unable to produce stools on the third day post-surgery,  neostigmine (Prostigmin® 0.5 mg subcutaneous, maximum 4 times a day), an acetylcholinesterase inhibitor promoting the movement of intestinal contents by augmenting motor activity of the small and large bowel, can be administered. Only if oral intake is still insufficient after five days, PN (Oliclinomel N7) can be initiated.</description>
    <arm_group_label>Enhanced Recovery Oral Nutrition Protocol (ERONP) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>Subjects enrolled in this arm will undergo usual medical and pharmaceutical care. In this group, parenteral nutrition (Oliclinomel N7) is part of the routine postoperative care program.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unproblematic radical cystectomy

        Exclusion Criteria:

          -  preoperative contra-indications for enteral nutrition (EN): intestinal obstruction,
             malabsorption, multiple high-output fistula and intestinal ischemia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <lastchanged_date>January 23, 2013</lastchanged_date>
  <firstreceived_date>January 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cystectomy</keyword>
  <keyword>parenteral nutrition</keyword>
  <keyword>discharge</keyword>
  <keyword>outcome</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
